p16ink4a is a surrogate marker for high-risk and malignant cervical lesions in the presence of human papillomavirus

Pathobiology. 2009 May;76(3):141-8. doi: 10.1159/000209392. Epub 2009 May 19.

Abstract

Objective: To strengthen the role of high-risk human papillomaviruses (HPVs) in the development of cervical cancer, and the association between HPV and the cell cycle inhibitor gene p16ink4a in cervical carcinogenesis.

Methods: In this study, the association between p16ink4a and the presence of HPV DNA in cervical lesions was investigated in a total of 177 cervical biopsies classified as benign (n = 42), low-grade squamous intraepithelial lesions (LSIL; n = 34), high-grade squamous intraepithelial lesions (HSIL; n = 48) and invasive cancer (n = 53). p16ink4a expression was analyzed by immunohistochemistry while HPV DNA was localized by in situ hybridization.

Results: No significant association was found between p16ink4a expression and HPV presence in benign and LSIL samples. In HSIL and invasive cancer, a significant association was found between p16ink4a overexpression and the presence of HPV DNA.

Conclusion: Immunohistochemical p16ink4a expression is associated with HPV infection in HSIL and cervical cancer, suggesting a role of p16 as a biomarker of HPV-associated cervical lesions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / virology
  • Female
  • Gene Expression
  • Genes, p16*
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Papillomavirus Infections / complications*
  • Risk Factors
  • Uterine Cervical Dysplasia / genetics
  • Uterine Cervical Dysplasia / virology
  • Uterine Cervical Neoplasms / genetics*
  • Uterine Cervical Neoplasms / pathology*
  • Uterine Cervical Neoplasms / virology*

Substances

  • Biomarkers, Tumor